TGTX analyst estimates
TG Therapeutics (TGTX) analyst ratings, the average price target and its range, and every firm's latest call.
TGTX analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Aug 4, 2026 | H.C. Wainwright | TG Therapeutics (TGTX) PT Raised to $78 at H.C. Wainwright | $78.00 |
| Jun 22, 2026 | Jefferies | TG Therapeutics price target raised to $83 from $57 at Jefferies | $83.00 |
| May 6, 2026 | H.C. Wainwright | TG Therapeutics price target raised to $70 from $60 at H.C. Wainwright | $70.00 |
| Jan 15, 2026 | Goldman Sachs | TG Therapeutics price target raised to $39 from $37 at Goldman Sachs | $39.00 |
| Oct 6, 2025 | H.C. Wainwright | TG Therapeutics assumed with a Buy at H.C. Wainwright | $60.00 |
| Nov 5, 2024 | H.C. Wainwright | TG Therapeutics (TGTX) PT Raised to $55 at H.C. Wainwright | $55.00 |
| Aug 6, 2024 | Goldman Sachs | TG Therapeutics price target raised to $20 from $18 at Goldman Sachs | $20.00 |
| May 3, 2024 | H.C. Wainwright | TG Therapeutics (TGTX) PT Raised to $49 at H.C. Wainwright | $49.00 |
| Feb 7, 2023 | Cantor Fitzgerald | Cantor Fitzgerald Maintains Overweight on TG Therapeutics, Raises Price Target to $24 | $24.00 |
| Dec 30, 2022 | Evercore ISI | Evercore ISI Group Maintains Outperform on TG Therapeutics, Raises Price Target to $16 | $16.00 |
| Dec 29, 2022 | H.C. Wainwright | TG Therapeutics price target raised to $24 from $19 at H.C. Wainwright | $24.00 |
| Apr 19, 2022 | Goldman Sachs | Goldman Sachs Maintains Sell on TG Therapeutics, Lowers Price Target to $5 | $5.00 |
| Apr 18, 2022 | Telsey Advisory | Has TG Therapeutics Stock Hit Bottom? Looking for the Silver Lining | $23.00 |
- 5 firms rate TGTX: 3 buy, 1 hold, 1 sell.
- The average price target is $80.50 from 2 analysts, from $78.00 to $83.00.
Updated 2026-11-02 17:14 UTC